Skip to content

The influence of remimazolam on cardiac output in coronary artery bypass grafting

The influence of remimazolam on cardiac output in coronary artery bypass grafting

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056299
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Group R:giving remimazolam 0.2-0.3mg/kg in induction
Group P:giving propofol 1-2mg/kg in induction
Group E:giving etomidate 0.1-0.2mg/kg in induction

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.ASA physical status I-IV; 2.BMI 18-20 kg/m^2; 3.Aged above 18 years; 4.Prepare to have coronary artery bypass grafting under general anesthesia; 5.Selective operation.

Exclusion criteria

Exclusion criteria: 1. Female in pregnancy or lactation and anyone prepare to give birth; 2. Having severe organ dysfunction in respiratory or circulation system or having abnormality in CBC and CMP; 3. Having severe mental illness or disease in nervous system; 4. Having benzodiazepines or opioids everyday in a month or once for two days; 5. Allergic or having contradiction using benzodiazepines, opioids, propofol, flumazenil, naloxone and their ingredients; 6. Ruled as patient with difficult airway: mallmapati score above III.

Design outcomes

Primary

MeasureTime frame
cardiac output;

Secondary

MeasureTime frame
cardiac index;stroke volume;system vascular resistance index;blood pressure;heart rate;the amount of vasoactive drug;

Countries

China

Contacts

Public ContactMa Jun

Beijing Anzhen Hosptial, Capital Medical University

majun7689@163.com+86 138 1103 1060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026